Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Astria Therapeutics Inc (NASDAQ: ATXS) closed at $12.51 in the last session, down -1.65% from day before closing price of $12.72. In other words, the price has decreased by -$1.65 from its previous closing price. On the day, 0.85 million shares were traded. ATXS stock price reached its highest trading level at $12.74 during the session, while it also had its lowest trading level at $12.5.
Ratios:
We take a closer look at ATXS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 10.78 and its Current Ratio is at 10.78. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On September 17, 2025, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $16 to $20.
On April 29, 2025, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $47.Cantor Fitzgerald initiated its Overweight rating on April 29, 2025, with a $47 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXS now has a Market Capitalization of 714131392 and an Enterprise Value of 586193344. For the stock, the TTM Price-to-Sale (P/S) ratio is 1005.82 while its Price-to-Book (P/B) ratio in mrq is 5.12. Its current Enterprise Value per Revenue stands at 830.302.
Stock Price History:
The Beta on a monthly basis for ATXS is 0.20, which has changed by 0.6328627 over the last 52 weeks, in comparison to a change of 0.1726681 over the same period for the S&P500. Over the past 52 weeks, ATXS has reached a high of $13.29, while it has fallen to a 52-week low of $3.56. The 50-Day Moving Average of the stock is -1.77%, while the 200-Day Moving Average is calculated to be 55.21%.
Shares Statistics:
According to the various share statistics, ATXS traded on average about 2.10M shares per day over the past 3-months and 582320 shares per day over the past 10 days. A total of 56.43M shares are outstanding, with a floating share count of 50.04M. Insiders hold about 12.34% of the company’s shares, while institutions hold 82.38% stake in the company. Shares short for ATXS as of 1767139200 were 5752164 with a Short Ratio of 2.74, compared to 1764288000 on 4813071. Therefore, it implies a Short% of Shares Outstanding of 5752164 and a Short% of Float of 12.65.
Earnings Estimates
A comprehensive evaluation of Astria Therapeutics Inc (ATXS) is underway, with the input of 3 analysts contributing to its current rating.The consensus estimate for the next quarter is -$0.6, with high estimates of -$0.54 and low estimates of -$0.65.
Analysts are recommending an EPS of between -$2.0 and -$2.26 for the fiscal current year, implying an average EPS of -$2.12. EPS for the following year is -$2.36, with 4.0 analysts recommending between -$2.01 and -$2.75.
